Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
Cell Reports|April 18, 2019
Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung CancerHyejin Choi, Jiehui Deng, Shuai Li, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2018
An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine ModelsEla Markovsky, Sadna Budhu, Robert M Samstein, et al.
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
Cell Reports|January 13, 2021
Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of MelanomaSadna Budhu, Rachel Giese, Aditi Gupta, et al.
Cancer Research|June 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clonesMariam Mathew George, Linda Hamadene, Yacine Marouf, et al.
Life Science Alliance|October 27, 2023
APR-246 increases tumor antigenicity independent of p53Judith Michels, Divya Venkatesh, Cailian Liu, et al.
Plos One|May 19, 2012
Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domainHua Cao, Peihong Dai, Weiyi Wang, et al.
Molecular Therapy. Oncology|September 23, 2024
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma modelsChristopher S Hackett, Daniel Hirschhorn, Meixian S Tang, et al.
Cancer Immunology Research|January 14, 2014
Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitorMargaret K Callahan, Gregg Masters, Christine A Pratilas, et al.
Cancer Cell|June 13, 2018
Non-conventional Inhibitory CD4<sup>+</sup>Foxp3<sup>-</sup>PD-1<sup>hi</sup> T Cells as a Biomarker of Immune Checkpoint Blockade ActivityRoberta Zappasodi, Sadna Budhu, Matthew D Hellmann, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
Cell Reports|April 18, 2019
Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung CancerHyejin Choi, Jiehui Deng, Shuai Li, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2018
An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine ModelsEla Markovsky, Sadna Budhu, Robert M Samstein, et al.
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
Cell Reports|January 13, 2021
Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of MelanomaSadna Budhu, Rachel Giese, Aditi Gupta, et al.
Cancer Research|June 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clonesMariam Mathew George, Linda Hamadene, Yacine Marouf, et al.
Life Science Alliance|October 27, 2023
APR-246 increases tumor antigenicity independent of p53Judith Michels, Divya Venkatesh, Cailian Liu, et al.
Plos One|May 19, 2012
Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domainHua Cao, Peihong Dai, Weiyi Wang, et al.
Molecular Therapy. Oncology|September 23, 2024
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma modelsChristopher S Hackett, Daniel Hirschhorn, Meixian S Tang, et al.
Cancer Immunology Research|January 14, 2014
Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitorMargaret K Callahan, Gregg Masters, Christine A Pratilas, et al.
Cancer Cell|June 13, 2018
Non-conventional Inhibitory CD4<sup>+</sup>Foxp3<sup>-</sup>PD-1<sup>hi</sup> T Cells as a Biomarker of Immune Checkpoint Blockade ActivityRoberta Zappasodi, Sadna Budhu, Matthew D Hellmann, et al.
Pageof 22